Sci III - Process Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Thermo Fisher Scientific · 3 weeks ago

Sci III - Process Development

Thermo Fisher Scientific Inc. is the world leader in serving science, and they are seeking a Scientist III for their Downstream Process Development team. The role involves planning, designing, and implementing laboratory activities while serving as a subject matter expert in downstream processing for viral vectors.

BioinformaticsBiotechnologyCloud Data ServicesConsultingHealth CareLife ScienceManagement Information SystemsOffice SuppliesPrecision Medicine
badNo H1Bnote

Responsibilities

Lead planning, tech transfer, process development and scale up activities (both bench and pilot scale) and preparing summary reports/presentations
Review and author documents (development plans, batch records, SOPs, protocols, summary reports), including deviation and/or investigational reports
Lead multiple projects; handle project tasks and timelines
Independently design experimental plans, perform studies, and analyze and report study results and recommendations both verbally and in written formats
Lead all aspects of downstream execution with members of the larger team while acting as a SME for downstream viral vector processing. Train junior team members
Collaborqate with clients, ensures accurate data and presentations to presented to clients. Assist in preparing detailed process development reports for products at different phase
Support sourcing, purchase, installation, startup and calibration and maintenance of Process Development equipment
Collaborate with global BPS team, Quality, and Project Management teams to facilitate technology transfer and project success
Lead Practical Process Improvement (PPI) initiatives

Qualification

Downstream processingChromatographyViral vector purificationCGMP knowledgeStatistical analysisCommunicationLeadership skillsInterpersonal skillsFlexibility

Required

B.S. in (bio)Chemical Engineering, Biochemistry, or related field with 5 yrs., Masters with 2 yrs. of industrial experience, or Ph.D
Design and execution of chromatography, tangential flow filtration, depth filtration, viral clearance, and ultracentrifugation studies to support scale up, development and characterization of gene therapy processes
Strong practical knowledge of downstream purification of mammalian and insect cell culture processes
Understanding of cGMP and regulatory requirements of biopharmaceutical manufacturing
Strong interpersonal and communications skills; written and oral
Ability to function in a fluid environment & balance priorities
Must be legally authorized to work in the United States now or in the future, without sponsorship
Must be able to pass a comprehensive background check, which includes a drug screening

Preferred

Prior viral vector purification experience is desired
Experience in scale up and scale down of purification processes
Experience with technology transfer, facility fit assessment, statistical analysis methodology and software (JMP or similar tools) is desired

Benefits

Medical, Dental, & Vision benefits-effective Day 1
Paid Time Off & Designated Paid Holidays
Retirement Savings Plan
Tuition Reimbursement
Employee assistance and family support programs, including commuter benefits and tuition reimbursement
At least 120 hours paid time off (PTO), 10 paid holidays annually, paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave), accident and life insurance, and short- and long-term disability in accordance with company policy
Retirement and savings programs, such as our competitive 401(k) U.S. retirement savings plan
Employees’ Stock Purchase Plan (ESPP) offers eligible colleagues the opportunity to purchase company stock at a discount

Company

Thermo Fisher Scientific

company-logo
Thermo Fisher Scientific is a biotechnology and laboratory equipment company that provides a wide range of scientific products and services.

Funding

Current Stage
Public Company
Total Funding
$15.97B
Key Investors
National Grid
2025-11-24Post Ipo Debt· $2.42B
2025-09-30Post Ipo Debt· $2.5B
2023-08-07Post Ipo Debt· $2.95B

Leadership Team

leader-logo
Stephen Williamson
Senior Vice President and Chief Financial Officer
linkedin
leader-logo
Daniella Cramp
Senior Vice President and President, Bioproduction Group
linkedin
Company data provided by crunchbase